135 related articles for article (PubMed ID: 1564451)
1. Infection enhancement of influenza A NWS virus in primary murine macrophages by anti-hemagglutinin monoclonal antibody.
Ochiai H; Kurokawa M; Matsui S; Yamamoto T; Kuroki Y; Kishimoto C; Shiraki K
J Med Virol; 1992 Mar; 36(3):217-21. PubMed ID: 1564451
[TBL] [Abstract][Full Text] [Related]
2. Infection enhancement of influenza A H1 subtype viruses in macrophage-like P388D1 cells by cross-reactive antibodies.
Ochiai H; Kurokawa M; Kuroki Y; Niwayama S
J Med Virol; 1990 Apr; 30(4):258-65. PubMed ID: 2370521
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to HA and NA augment uptake of influenza A viruses into cells via Fc receptor entry.
Tamura M; Webster RG; Ennis FA
Virology; 1991 May; 182(1):211-9. PubMed ID: 2024464
[TBL] [Abstract][Full Text] [Related]
4. The intersubunit region of the influenza virus haemagglutinin is recognized by antibodies during infection.
Nagy Z; Rajnavölgyi E; Hollósi M; Tóth GK; Váradi G; Penke B; Tóth I; Horváth A; Gergely J; Kurucz I
Scand J Immunol; 1994 Sep; 40(3):281-91. PubMed ID: 8091127
[TBL] [Abstract][Full Text] [Related]
5. Influenza Virus Overcomes Cellular Blocks To Productively Replicate, Impacting Macrophage Function.
Marvin SA; Russier M; Huerta CT; Russell CJ; Schultz-Cherry S
J Virol; 2017 Jan; 91(2):. PubMed ID: 27807237
[TBL] [Abstract][Full Text] [Related]
6. Neutralization and infection-enhancement epitopes of influenza A virus hemagglutinin.
Tamura M; Webster RG; Ennis FA
J Immunol; 1993 Aug; 151(3):1731-8. PubMed ID: 7687637
[TBL] [Abstract][Full Text] [Related]
7. A monoclonal antibody produced during infection which recognizes an epitope of influenza hemagglutinin only in the context of H-2k MHC class I antigen.
McLain L; Dimmock NJ
J Immunol; 1993 Apr; 150(8 Pt 1):3421-6. PubMed ID: 7682240
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies detect different forms of influenza virus hemagglutinin during viral penetration and biosynthesis.
Bächi T; Gerhard W; Yewdell JW
J Virol; 1985 Aug; 55(2):307-13. PubMed ID: 2410628
[TBL] [Abstract][Full Text] [Related]
9. [The trypsin cleavage of hemagglutinin enhances the infectivity of the influenza virus in mice].
Zhirnov OP
Vopr Virusol; 1990; 35(2):117-9. PubMed ID: 2389564
[TBL] [Abstract][Full Text] [Related]
10. Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins.
Marjuki H; Mishin VP; Chai N; Tan MW; Newton EM; Tegeris J; Erlandson K; Willis M; Jones J; Davis T; Stevens J; Gubareva LV
J Virol; 2016 Dec; 90(23):10446-10458. PubMed ID: 27630240
[TBL] [Abstract][Full Text] [Related]
11. Infection of Mouse Macrophages by Seasonal Influenza Viruses Can Be Restricted at the Level of Virus Entry and at a Late Stage in the Virus Life Cycle.
Londrigan SL; Short KR; Ma J; Gillespie L; Rockman SP; Brooks AG; Reading PC
J Virol; 2015 Dec; 89(24):12319-29. PubMed ID: 26423941
[TBL] [Abstract][Full Text] [Related]
12. Synergistic role of staphylococcal proteases in the induction of influenza virus pathogenicity.
Tashiro M; Ciborowski P; Reinacher M; Pulverer G; Klenk HD; Rott R
Virology; 1987 Apr; 157(2):421-30. PubMed ID: 3029981
[TBL] [Abstract][Full Text] [Related]
13. [Preparation and identification of monoclonal antibody against H1N1 influenza virus].
Liu Y; Zhao X; Guo C; Li Y; Wang G; Liang D; Yu P; Li Y; Hu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 May; 33(5):688-694. PubMed ID: 28502308
[TBL] [Abstract][Full Text] [Related]
14. Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules.
Tamura S; Funato H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
Eur J Immunol; 1991 Jun; 21(6):1337-44. PubMed ID: 1646112
[TBL] [Abstract][Full Text] [Related]
15. Interference between influenza A viruses with a cleavable and a noncleavable hemagglutinin; pH-stability after mixed infection.
Scholtissek C; Müller K
Arch Virol; 1988; 101(1-2):119-23. PubMed ID: 3415477
[TBL] [Abstract][Full Text] [Related]
16. The hemagglutinin: a determinant of pathogenicity.
Böttcher-Friebertshäuser E; Garten W; Matrosovich M; Klenk HD
Curr Top Microbiol Immunol; 2014; 385():3-34. PubMed ID: 25031010
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of monoclonal antibodies to a synthetic peptide of influenza haemagglutinin on the processing and presentation of viral antigens to class II-restricted T-cell clones.
Mills KH
Immunology; 1988 Nov; 65(3):365-71. PubMed ID: 2463222
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies to glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin.
Russ G; Poláková K; Kostolanský F; Styk B; Vancíková M
Acta Virol; 1987 Sep; 31(5):374-86. PubMed ID: 2891276
[TBL] [Abstract][Full Text] [Related]
19. Murine leukemia virus R Peptide inhibits influenza virus hemagglutinin-induced membrane fusion.
Li M; Li ZN; Yao Q; Yang C; Steinhauer DA; Compans RW
J Virol; 2006 Jun; 80(12):6106-14. PubMed ID: 16731949
[TBL] [Abstract][Full Text] [Related]
20. Passive immune-prophylaxis against influenza virus infection by the expression of neutralizing anti-hemagglutinin monoclonal antibodies from plasmids.
Yamazaki T; Nagashima M; Ninomiya D; Arai Y; Teshima Y; Fujimoto A; Ainai A; Hasegawa H; Chiba J
Jpn J Infect Dis; 2011; 64(1):40-9. PubMed ID: 21266754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
